Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-10-18 00:00:00 ET · period of report 2024-10-16 · accession 0000950170-24-115725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-10-18 | 2024-10-16 | WVE | BOLNO PAUL | Pres, CEO, Dir | S - Sale | $15.00 | -90.5K | 268.6K | -25% | -$1.36M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-10-16 | S | D | 90,474 | $15.00 | 268,585 | D | — | — |